Why the study?
Does a composite clinical and CMR-based risk score provide incremental prognostic value beyond standard of care evaluation in patients with non-ischaemic dilated cardiomyopathy?
Does a composite clinical and CMR-based risk score provide incremental prognostic value beyond standard of care evaluation in patients with non-ischaemic dilated cardiomyopathy?
A combined clinical and CMR-based risk score improves prognostic assessment for ICD implantation in patients with non-ischemic dilated cardiomyopathy compared to standard evaluation.
May refine ICD risk stratification in non-ischaemic dilated cardiomyopathy; leaves open prospective validation of clinical impact.
In a large multicentre, multivendor cohort registry reflecting daily clinical practice in NICM work-up, a composite clinical and CMR-based risk score provides incremental prognostic value beyond SOC evaluation, which may have impact on the indication of implantable cardioverter-defibrillator implantation.
No takes yet. Share an insight, caveat, or question.
Guaricci et al. (2020) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: